| 1 |
31133859 | The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors. | 2019 |
1 |
| 2 |
29318243 | Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides. | 2018 Mar 1 |
1 |
| 3 |
28677116 | DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. | 2017 Oct 15 |
1 |
| 4 |
26871298 | Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line. | 2016 Mar 7 |
1 |
| 5 |
24861759 | Intestinal transport of sophocarpine across the Caco-2 cell monolayer model and quantification by LC/MS. | 2014 Jun |
1 |
| 6 |
22359351 | Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. | 2012 May |
1 |
| 7 |
19541926 | Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. | 2009 Aug |
1 |